Genotyping Market
Genotyping Market Forecasts to 2028 - Global Analysis By Product & Service (Genotyping Services, Bioinformatics and Others), Technology (Sequencing, Microarrays, MALDI-TOF, Capillary Electrophoresis and Other Technologies), Application, End User and By Geography
|
Years Covered |
2020-2028 |
|
Estimated Year Value (2022) |
US $27.89 BN |
|
Projected Year Value (2028) |
US $101.41BN |
|
CAGR (2022 - 2028) |
24.0% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Genotyping Market is accounted for $27.89 billion in 2022 and is expected to reach $101.41 billion by 2028 growing at a CAGR of 24.0% during the forecast period. Genotyping is a method that uses an individual's DNA sequence to examine genetic make-up variations using biological experiments. This method aids scientists in examining genetic anomalies such significant DNA structural variations and single nucleotide polymorphisms. The advent of innovative technologies that significantly reduce mistakes and produce effective findings, as well as the rising prevalence of target diseases including cancer, diabetes, and Alzheimer's, fuel the market's growth.
According to WHO, 19.1 million new cancer cases were diagnosed using genotyping globally in 2020. Cancer-causing viruses such as Human Papilloma Virus (HPV) and Hepatitis B Virus (HBV)/Hepatitis C Virus (HCV) are also responsible for about 20% of cancer deaths worldwide.
Market Dynamics:
Driver:
Technological advances and falling DNA sequencing costs
Miniaturisation, automation, lower overall costs, operational flexibility, and the inclusion of multi-parameter testing have all been made possible by technological breakthroughs. All of them have significantly improved the versatility and uses of DNA sequencing, freeing doctors to concentrate on important choices like selecting and prioritising therapeutic targets through diverse genotyping research. As a result, technologies like capillary electrophoresis, microarrays, PCR, sequencing, and sequencing have seen an increase in use in areas like clinical research and drug development.
Restraint:
High cost of equipment
The equipment needed to conduct genotyping testing is quite expensive, and a significant financial expenditure is needed to install it. Genotyping equipment is expensive since it has sophisticated features and capabilities. Such systems are needed by pharmaceutical corporations and research facilities in large quantities, necessitating considerable investments to buy numerous, expensive genotyping devices. The overall rise in the total cost of ownership of these instruments is brought on by maintenance costs as well as a number of other indirect costs, including sample and labour costs. As a result, academic and research institutions struggle to install and expand cutting-edge research facilities like NGS technology which are hindering the growth of the market.
Opportunity:
Expanding application fields
Applications for genotyping systems include pharmacogenomics, diagnostic research, individualised medicine, and forensics. Additionally, this technology is suitable for various veterinary requirements, testing for food safety and quality, and environmental conditions in rural and industrial settings. Currently, the demand for better treatment choices and the high frequency of disease make human diagnostics and pharmacogenomics segments that have great marker potential. These segments also require quick genotyping analysis on a wide scale creating a wide range of opportunities for the growth of the market.
Threat:
Research using genotyping data management
Genotyping investigations both quantitatively and qualitatively provide enormous amounts of data. Previously, this data was manually saved, but this posed a significant issue because up to terabytes of data may be created in only a few hours. Through the development of databases to store genotyping data, technological improvements have made it possible to automate the data storage procedure.
Covid-19 Impact
Technology advances, an increase in the frequency of cancer and genetic abnormalities, and increased R&D investment for precision medicine research are all factors contributing to the expansion. The pandemic raised demand for COVID-19 genotyping kits, which has had a favourable effect on the genotyping business. The genetic variations of COVID-19 have been found using SNP genotyping. The genotyping industry is anticipated to be driven by an increase in government financing, particularly for genomic research, by governmental organisations and pharmaceutical and biotechnology firms to speed up research.
The product & service segment is expected to be the largest during the forecast period
The product & service segment is estimated to have a lucrative growth, due to the availability of a wide variety of reagents, the rising demand for reagents as a result of the increased volume of genotyping tests performed globally, and the relatively low capital expenditure needed to adopt reagents and kits for genotyping in hospitals and diagnostic labs are the factors contributing to the high growth.
The pharmacogenomics segment is expected to have the highest CAGR during the forecast period
The pharmacogenomics segment is anticipated to witness the highest CAGR growth during the forecast period. Pharmacogenomics is the study of how genes impact how an individual reacts to medications. This area integrates the study of genes and their roles with the science of pharmaceuticals to create effective, secure treatments that may be provided depending on a person's genetic profile. Pharmacogenomics will be utilised in the future to create custom medications to address a variety of health issues, such as cardiovascular disease, Alzheimer's disease, cancer, and asthma thus propelling the growth of the market.
Region with highest share:
North America is projected to hold the highest market share during the forecast period owing to the growing use of technologically sophisticated goods, the existence of significant pharmaceutical and biopharmaceutical businesses, pro-active government policies, and improvements in healthcare infrastructure. Another important element contributing to the high market share in this area is the existence of big companies. Growing demand from pharmaceutical companies for genotyping products, rising government investment, increasing adoption of technologically advanced genotyping products, high healthcare expenditures
Region with highest CAGR:
Asia Pacific is projected to have the highest CAGR over the forecast period, due to the vast untapped potential and rising number of clinical trials being carried out in this area. Growth in the market is anticipated as a result of factors such as the FDA's recommendations to incorporate pharmacogenomics research & genotyping in the drug discovery process and the expanding demand for pharmacogenomics in the drug development process. Other causes, such as technical developments and the expanding pharma and biopharma industries in the area, might also be blamed for this expansion.
Key players in the market
Some of the key players profiled in the Genotyping Market include Illumina Inc., QIAGEN, Fluidigm Corporation, Agilent Technologies, Danaher Corporation, Thermo Fisher Scientific Inc., Eurofins Scientific Inc., Bio-Rad Laboratories Inc., GE Healthcare Inc., Thermo Fisher Scientific, PerkinElmer, Pacific Biosciences of California, Integrated DNA Technologies, GENEWIZ, Biofortuna Limited, Precision Biomarker Resources, Inc. and TrimGen Corporation
Key Developments:
In April 2023, Agilent and Theragen Bio Partner to Advance Bioinformatic Solutions for Cancer Genomic Profiling in South Korea, New collaboration combines Agilent’s SureSelect Cancer CGP assay and Theragen Bio’s localized analysis software to transform translational research and enhance precision oncology
In April 2023, Agilent and PathAI Partner to Deliver AI-Powered Assay Development Solutions for Biopharma Research and Clinical Applications, By incorporating AI into CDx development, the partnership enables Agilent and PathAI to build integrated solutions with assays and machine learning analysis algorithms.
In Nov 2022, Danaher launches beacon initiative and its first partnership focused on gene therapy innovation, the program invests in product innovation to advance external R&D strategies with a focus on genomic medicines, precision diagnostics, next generation biomanufacturing, human systems, and data sciences.
Products & Services Covered:
• Genotyping Services
• Bioinformatics
• Instruments
• Reagents & Kit
Technologies Covered:
• Sequencing
• Microarrays
• PCR
• MALDI-TOF
• Capillary Electrophoresis
• Other Technologies
Applications Covered:
• Diagnostic & Personalized Medicine
• Animal Genetics
• Pharmacogenomics
• Other Applications
End Users Covered:
• Pharmaceutical & Biopharmaceutical Companies
• Academic Institutes
• Research & Diagnostic Laboratories
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Genotyping Market, By Product & Service
5.1 Introduction
5.2 Genotyping Services
5.3 Bioinformatics
5.3.1 Software
5.3.2 Services
5.4 Instruments
5.4.1 Analyzers
5.4.2 Sequencers & Amplifiers
5.5 Reagents & Kit
6 Global Genotyping Market, By Technology
6.1 Introduction
6.2 Sequencing
6.2.1 Pyrosequencing
6.2.2 NGS
6.2.3 Sanger Sequencing
6.3 Microarrays
6.4 PCR
6.4.1 Real-Time PCR
6.4.2 Digital PCR
6.5 MALDI-TOF
6.6 Capillary Electrophoresis
6.6.1 Restricted Fragment Length Polymorphism
6.6.2 Single-stranded Conformation Polymorphism
6.6.3 Amplified Fragment Length Polymorphism
6.7 Other Technologies
7 Global Genotyping Market, By Application
7.1 Introduction
7.2 Diagnostic & Personalized Medicine
7.3 Animal Genetics
7.4 Pharmacogenomics
7.5 Other Applications
8 Global Genotyping Market, By End User
8.1 Introduction
8.2 Pharmaceutical & Biopharmaceutical Companies
8.3 Academic Institutes
8.4 Research & Diagnostic Laboratories
8.5 Other End Users
9 Global Genotyping Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Illumina Inc.
11.2 QIAGEN
11.3 Fluidigm Corporation
11.4 Agilent Technologies
11.5 Danaher Corporation
11.6 Thermo Fisher Scientific Inc.
11.7 Eurofins Scientific Inc.
11.8 Bio-Rad Laboratories Inc.
11.9 GE Healthcare Inc.
11.10 Thermo Fisher Scientific
11.11 PerkinElmer
11.12 Pacific Biosciences of California
11.13 Integrated DNA Technologies
11.14 GENEWIZ
11.15 Biofortuna Limited
11.16 Precision Biomarker Resources, Inc.
11.17 TrimGen Corporation
List of Tables
1 Global Genotyping Market Outlook, By Region (2020-2028) ($MN)
2 Global Genotyping Market Outlook, By Product & Service (2020-2028) ($MN)
3 Global Genotyping Market Outlook, By Genotyping Services (2020-2028) ($MN)
4 Global Genotyping Market Outlook, By Bioinformatics (2020-2028) ($MN)
5 Global Genotyping Market Outlook, By Software (2020-2028) ($MN)
6 Global Genotyping Market Outlook, By Services (2020-2028) ($MN)
7 Global Genotyping Market Outlook, By Instruments (2020-2028) ($MN)
8 Global Genotyping Market Outlook, By Analyzers (2020-2028) ($MN)
9 Global Genotyping Market Outlook, By Sequencers & Amplifiers (2020-2028) ($MN)
10 Global Genotyping Market Outlook, By Reagents & Kit (2020-2028) ($MN)
11 Global Genotyping Market Outlook, By Technology (2020-2028) ($MN)
12 Global Genotyping Market Outlook, By Sequencing (2020-2028) ($MN)
13 Global Genotyping Market Outlook, By Pyrosequencing (2020-2028) ($MN)
14 Global Genotyping Market Outlook, By NGS (2020-2028) ($MN)
15 Global Genotyping Market Outlook, By Sanger Sequencing (2020-2028) ($MN)
16 Global Genotyping Market Outlook, By Microarrays (2020-2028) ($MN)
17 Global Genotyping Market Outlook, By PCR (2020-2028) ($MN)
18 Global Genotyping Market Outlook, By Real-Time PCR (2020-2028) ($MN)
19 Global Genotyping Market Outlook, By Digital PCR (2020-2028) ($MN)
20 Global Genotyping Market Outlook, By MALDI-TOF (2020-2028) ($MN)
21 Global Genotyping Market Outlook, By Capillary Electrophoresis (2020-2028) ($MN)
22 Global Genotyping Market Outlook, By Restricted Fragment Length Polymorphism (2020-2028) ($MN)
23 Global Genotyping Market Outlook, By Single-stranded Conformation Polymorphism (2020-2028) ($MN)
24 Global Genotyping Market Outlook, By Amplified Fragment Length Polymorphism (2020-2028) ($MN)
25 Global Genotyping Market Outlook, By Other Technologies (2020-2028) ($MN)
26 Global Genotyping Market Outlook, By Application (2020-2028) ($MN)
27 Global Genotyping Market Outlook, By Diagnostic & Personalized Medicine (2020-2028) ($MN)
28 Global Genotyping Market Outlook, By Animal Genetics (2020-2028) ($MN)
29 Global Genotyping Market Outlook, By Pharmacogenomics (2020-2028) ($MN)
30 Global Genotyping Market Outlook, By Other Applications (2020-2028) ($MN)
31 Global Genotyping Market Outlook, By End User (2020-2028) ($MN)
32 Global Genotyping Market Outlook, By Pharmaceutical & Biopharmaceutical Companies (2020-2028) ($MN)
33 Global Genotyping Market Outlook, By Academic Institutes (2020-2028) ($MN)
34 Global Genotyping Market Outlook, By Research & Diagnostic Laboratories (2020-2028) ($MN)
35 Global Genotyping Market Outlook, By Other End Users (2020-2028) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
